Skip to main content
TipRanks
Go Ultimate75% OFF

Kriti Nutrients Limited (KRITINUT) AI Stock Analysis

0 Followers
IN:KRITINUT

Kriti Nutrients Limited

(NSE:KRITINUT)

Select Model
Rating:67Neutral
Price Target:INR 77.00â–²(17.38% Upside)
Action:downgraded
Date:10/29/26

The score is primarily supported by a conservative balance sheet and strong current cash generation. However, substantial profitability and margin deterioration, together with a bearish technical trend, materially constrain the outlook. The low P/E provides some valuation support, while the modest dividend yield offers limited additional benefit.

Positive Factors
Conservative balance sheetVery low leverage and a steadily expanding equity base provide financial flexibility through commodity and earnings cycles. Limited debt exposure reduces interest and refinancing pressure, allowing the company to retain more cash for operations, resilience, and future growth.
Negative Factors
Significant margin compressionThe substantial decline in gross and net margins shows that revenue growth is currently producing lower-quality earnings. Continued input-cost or pricing pressure could limit profit conversion, weaken returns, and require stronger operational performance before higher sales translate into durable earnings growth.

Kriti Nutrients Limited (KRITINUT) vs. iShares MSCI India ETF (INDA)

-40%-30%-20%-10%0%10%20%IN:KRITINUT-23.69%INDA-5.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 3.25B
Dividend Yield
0.46%
Average Volume (3M)
1,827
Price to Earnings (P/E)
10.8
Beta (1Y)
1.46
Revenue Growth
17.56%
EPS Growth
-4.84%
Country
India
Employees
234
Sector
General
Sector Strength
55
Industry
Packaged Foods

Kriti Nutrients Limited Business Overview & Revenue Model

Company Description

Kriti Nutrients Limited, established in 1992 and headquartered in Indore, India, operates in the manufacturing and global distribution of soybean seeds under its "Kriti" brand. The company's extensive product range includes various edible oils such a...

Kriti Nutrients Limited Financial Statement Overview

Summary

Strong balance-sheet quality and cash generation support the score: equity increased, debt declined to ₹91 million, debt-to-equity was 0.040, and operating cash flow rose 119%. These strengths are partly offset by significant margin compression and an 8.4% decline in net income despite revenue growth.

Income Statement

72Positive

Balance Sheet

78Positive

Cash Flow

75Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue9.58B9.22B7.34B6.83B7.96B7.51B
Gross Profit724.28M748.03M1.03B1.07B780.37M679.84M
EBITDA424.50M434.39M557.89M666.67M356.28M222.83M
Net Income300.24M339.01M369.94M452.87M207.98M123.05M
Balance Sheet
Total Assets2.83B2.73B2.38B2.09B1.93B1.68B
Cash, Cash Equivalents and Short-Term Investments497.70M622.12M265.85M210.43M190.38M37.16M
Total Debt102.34M91.01M30.69M121.45M403.73M375.58M
Total Liabilities391.88M435.96M259.39M325.25M607.00M554.76M
Stockholders Equity2.44B2.29B2.12B1.76B1.32B1.13B
Cash Flow
Free Cash Flow0642.82M273.10M409.62M133.43M-193.72M
Operating Cash Flow0698.45M319.58M498.13M198.61M-105.10M
Investing Cash Flow0-152.65M-288.64M-291.87M-31.35M-199.81M
Financing Cash Flow0-100.33M-106.49M-304.01M-14.05M311.86M

Kriti Nutrients Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price65.60

Price Trends

50DMA73.14Negative
100DMA77.58Negative
200DMA77.78Negative

Market Momentum

MACD-1.94Negative
RSI44.11Neutral
STOCH51.90Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KRITINUT, the sentiment is Negative. The current price of 65.60 is below the 20-day moving average (MA) of 66.37, below the 50-day MA of 73.14, and below the 200-day MA of 77.78, indicating a bearish trend. The MACD of -1.94 indicates Negative momentum. The RSI at 44.11 is Neutral, neither overbought nor oversold. The STOCH value of 51.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:KRITINUT.

Kriti Nutrients Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:KRITINUT against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:GOKULAGROIN:GOKULAGRO81OutperformINR 66.90B14.35――14.83%58.34%
IN:KRITINUTIN:KRITINUT67NeutralINR 3.29B10.81―0.46%17.56%-4.84%
IN:MUKKAIN:MUKKA61NeutralINR 7.97B10.03――84.77%67.73%
IN:ROMLIN:ROML56NeutralINR 663.53M14.93――15.31%-22.36%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:MKPLIN:MKPL47NeutralINR 1.46B30.82――17.76%-50.16%
IN:GOKULIN:GOKUL42NeutralINR 3.69B17.79――15.39%27.60%

* General Sector Average

Performance Comparison

-40%-20%0%20%IN:KRITINUTIN:GOKULIN:GOKULAGROIN:MKPLIN:MUKKAIN:ROMLDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:KRITINUT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:KRITINUTKriti Nutrients Limited65.60-20.65-23.94%
IN:GOKULGokul Refoils & Solvent Ltd.37.32-2.59-6.49%
IN:GOKULAGROGokul Agro Resources Ltd.226.7026.0012.95%
IN:MKPLM K Proteins Limited3.89-2.62-40.25%
IN:MUKKAMukka Proteins Limited26.580.441.68%
IN:ROMLRaj Oil Mills Limited41.50-15.02-26.57%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 29, 2026